CN100394925C - Chinese medicinal composition for treating rheumatism rheumatoid arthritis and osteosis - Google Patents
Chinese medicinal composition for treating rheumatism rheumatoid arthritis and osteosis Download PDFInfo
- Publication number
- CN100394925C CN100394925C CNB031559255A CN03155925A CN100394925C CN 100394925 C CN100394925 C CN 100394925C CN B031559255 A CNB031559255 A CN B031559255A CN 03155925 A CN03155925 A CN 03155925A CN 100394925 C CN100394925 C CN 100394925C
- Authority
- CN
- China
- Prior art keywords
- weight portion
- rheumatoid arthritis
- osteosis
- weight
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention discloses a Chinese medicinal composition used for treating rheumatism, rheumatoid arthritis and osteosis, which is prepared from scorpion, centipede, earthworm, pangolin, eupolyphage sinensis, silky ant, long-noded pit viper and xylotrupes as raw medicinal materials. The present invention has significant effect on treating rheumatism, rheumatoid arthritis and osteosis.
Description
Technical field
The present invention relates to a kind of pharmaceutical composition, particularly relate to a kind of Chinese medicine composition for the treatment of rheumatism, rheumatoid arthritis and hyperosteogeny
Background technology
Rheumatism is that a kind of common clinical, frequently-occurring disease, disease cycle are longer, and the clinical symptoms performance is various, the stubborn disease that the treatment phase is long.Hyperosteogeny is the aged a kind of performance of skeleton, also is one of common frequently-occurring disease of old people.Present domestic medical circle treatment hyperosteogeny main method has: traction, massage, surgical operation etc., and these Therapeutic Method cause very big misery to the patient, and the treatment condition has certain limitation, dangerous big, the course of treatment is long, and body is had damage, weak effect, more rate is low in treatment, easily recurrence.
Technology contents
The object of the present invention is to provide a kind of pharmaceutical composition that treatment rheumatism, rheumatoid arthritis, hyperosteogeny is had remarkable result.
The present invention is achieved through the following technical solutions:
Choose crude drug
Scorpio 10-50 weight portion Scolopendra 10-50 weight portion Pheretima 20-100 weight portion
Squama Manis 30-120 weight portion Eupolyphaga Seu Steleophaga 30-120 weight portion Formica fusca 50-150 weight portion
Agkistrodon 30-120 weight portion Catharsii molossi 20-100 weight portion
Optimum ratio of the present invention is:
Scorpio 30 weight portion Scolopendras 30 weight portion Pheretimas 50 weight portions
Squama Manis 60 weight portion Eupolyphaga Seu Steleophagas 60 weight portion Formica fuscas 100 weight portions
Agkistrodon 60 weight portion Catharsii molossis 50 weight portions
Press practice of pharmacy, compositions of the present invention can be added adjuvant and be prepared into the various clinical pharmaceutical dosage form, comprise any in tablet, capsule, granule, pill, suspensoid, drop pill, the oral liquid.
Described adjuvant is meant conventional excipient, as solvent, disintegrating agent, correctives, antiseptic, coloring agent, binding agent etc.
Following experimental example is used to further specify the present invention.
Clinical data:
This clinical verification was observed from year February in February, 2000 to 2003, and the utilization present composition is treated rheumatism, rheumatoid arthritis, hyperosteogeny patient's 650 examples, wherein male 390 examples, women 260 examples altogether.Instructions of taking every day 3 times, each 4, two weeks were a course of treatment.The present invention treats rheumatism, rheumatoid arthritis, hyperosteogeny effective percentage 90%, cure rate 81%.
Model case:
Case 1: Jiang XX woman went to a doctor on August 28th, 56 years old.Extremities joint swelling distortion 5 years, sharp ache, difficulty in walking, through the multi-treatment poor effect, health is become thin, and purplish tongue is dark, thready and hesitant pulse.Look into: erythrocyte sedimentation rate 70mm/h, anti-" 0 " positive.Diagnosis: rheumatoid arthritis.Treatment: control the numbness sheet through clothes Chen Shi wind dispelling of the present invention, every day 3 times, each 4, swelling pain alleviates after the week, and 9 months complete, follows up a case by regular visits to and do not have recurrence in 2 years.
Case 2: what XX man 53 years old, suffered from lumbar vertebra hyperosteogeny disease 7 years, waist sacrum and lumbar and back pain are acutely accompanied moving obstacle unbearably, weakness of the waist and knees, erythrocyte sedimentation rate 80mm/h, Chinese medical discrimination: caused by liver and kidney deficiency silt essential resistance of turbid.Treatment: obey Chen Shi wind dispelling of the present invention and control the numbness sheet, every day 3 times, each 4, pain is basic after 3 days alleviates, and heals entirely after half a year.
Following embodiment all can realize the effect of above-mentioned experimental example.
Embodiment 1
Scorpio 30g Scolopendra 30g Pheretima 50g Squama Manis 60g Eupolyphaga Seu Steleophaga 60g
Formica fusca 10g Agkistrodon 60g Catharsii molossi 50g.
Said medicine technology is routinely made tablet, and every contains crude drug 0.5g, every day 3 times, each 4.
Embodiment 2:
Scorpio 25g Scolopendra 25g Pheretima 55g Squama Manis 65g Eupolyphaga Seu Steleophaga 55g
Formica fusca 15g Agkistrodon 55g Catharsii molossi 55g.
Said medicine technology is routinely made tablet.
Claims (3)
1. Chinese medicine composition for the treatment of rheumatism, rheumatoid arthritis and hyperosteogeny is characterized in that said composition made by following crude drug:
Scorpio 10-50 weight portion Scolopendra 10-50 weight portion Pheretima 20-100 weight portion
Squama Manis 30-120 weight portion Eupolyphaga Seu Steleophaga 30-120 weight portion Formica fusca 50-150 weight portion
Agkistrodon 30-120 weight portion Catharsii molossi 20-100 weight portion.
2. Chinese medicine composition according to claim 1 is characterized in that said composition made by following crude drug:
Scorpio 30 weight portion Scolopendras 30 weight portion Pheretimas 50 weight portions
Squama Manis 60 weight portion Eupolyphaga Seu Steleophagas 60 weight portion Formica fuscas 100 weight portions
Agkistrodon 60 weight portion Catharsii molossis 50 weight portions.
3. Chinese medicine composition according to claim 1 and 2 is characterized in that said composition adds adjuvant and is prepared into any in tablet, capsule, granule, pill, suspensoid, drop pill or the oral liquid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB031559255A CN100394925C (en) | 2003-08-27 | 2003-08-27 | Chinese medicinal composition for treating rheumatism rheumatoid arthritis and osteosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB031559255A CN100394925C (en) | 2003-08-27 | 2003-08-27 | Chinese medicinal composition for treating rheumatism rheumatoid arthritis and osteosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1589859A CN1589859A (en) | 2005-03-09 |
| CN100394925C true CN100394925C (en) | 2008-06-18 |
Family
ID=34598245
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB031559255A Expired - Fee Related CN100394925C (en) | 2003-08-27 | 2003-08-27 | Chinese medicinal composition for treating rheumatism rheumatoid arthritis and osteosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100394925C (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102836177B (en) * | 2012-09-13 | 2014-10-01 | 杜晓光 | Traditional Chinese medicine preparation for treating osteopathia |
| CN103655915A (en) * | 2013-11-28 | 2014-03-26 | 刘相英 | Capsule for treating rheumatoid bone diseases |
| CN103585350A (en) * | 2013-11-28 | 2014-02-19 | 刘相英 | Traditional Chinese medicine for treating rheumatism |
| CN105853518A (en) * | 2016-05-24 | 2016-08-17 | 刘金海 | Traditional Chinese medicine composition for treating rheumatoid diseases and preparation method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1433787A (en) * | 2002-01-19 | 2003-08-06 | 马献山 | Oral taken and external use medicine for antirheumatism and stopping numbness pain |
-
2003
- 2003-08-27 CN CNB031559255A patent/CN100394925C/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1433787A (en) * | 2002-01-19 | 2003-08-06 | 马献山 | Oral taken and external use medicine for antirheumatism and stopping numbness pain |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1589859A (en) | 2005-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102836177B (en) | Traditional Chinese medicine preparation for treating osteopathia | |
| CN100506274C (en) | Traditional Chinese medicine for treating cervical vertebra disease | |
| CN100571770C (en) | A kind of Chinese medicine cutaneous permeable agent | |
| CN101926957A (en) | Medicinal composition for treating arthralgia syndrome and preparation method thereof | |
| CN101129640A (en) | Medicine for reliving inflammation and pain | |
| CN102178807A (en) | Plaster for treating traumatic injury, pain in neck, waist and lower extremities, and rheumatoid arthritis | |
| CN102078527A (en) | Traditional Chinese medicine formula for treating urinary calculus | |
| CN100394925C (en) | Chinese medicinal composition for treating rheumatism rheumatoid arthritis and osteosis | |
| CN103356848A (en) | Traditional Chinese medicine and preparation method thereof as well as Chinese herba preparation and preparation method of plaster | |
| CN1389255A (en) | Composite Chinese medicine for treating rheumarthritis and rheumatoid arthritis | |
| CN100409894C (en) | Chinese proprietary medicine for treating cerebral thrombosis | |
| CN103393897B (en) | Externally used traditional Chinese medicine for treating hyperostosis and rheumatic ostealgia and preparation method thereof | |
| CN103751218A (en) | Traditional Chinese medicine composition for treating rheumatic and rheumatoid arthritis and osteoproliferation | |
| CN105267321A (en) | Medicine for treating gouty arthritis | |
| CN102406870A (en) | Medicament for treating rheumatic arthralgia | |
| CN102430096B (en) | Medicament for treating rheumatic or rheumatoid diseases | |
| CN101647880A (en) | Medicament for treating appendicitis and preparation method thereof | |
| CN101985013A (en) | Chinese herbal medicine for treating rheumatic arthritis | |
| CN101804179B (en) | Traditional Chinese medicine composition for treating hyperosteogeny of cervical vertebra and lumbar vertebra and preparation method thereof | |
| CN101195002B (en) | Chinese medicine emplastrum for releasing ache and health care | |
| CN1899564B (en) | External use medicine for treating hyperosteogeny and protrusion of intervertebral disc | |
| CN101361934B (en) | Traditional Chinese medicine preparation for treating arthritis and various osteonosus | |
| CN103585294A (en) | Plaster for treating osteoproliferation and preparation method of plaster | |
| CN102614350A (en) | Chinese medicine for treating cervical spondylosis | |
| CN103893436B (en) | A kind of externally applied drug for treating rheumatism |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080618 Termination date: 20110827 |